Driss Berdaï

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Off-label Prescriptions: how to Identify Them, Frame Them, Announce Them and Monitor Them in Practice?

Claire Le Jeunne, Nathalie Billon, Anne d’Andon et al. · Therapies · 2013 · 22 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +5

Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disorders

Arnaud Panes, Hélène Verdoux, Annie Fourrier‐Réglat et al. · British Journal of Clinical Pharmacology · 2019 · 21 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +14

Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso

Lassané Kaboré, Pascal Millet, Souleymane Fofana et al. · Drug Safety · 2013 · 20 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial

Fabrice Bonnet, Antoine Bénard, Pierre Poulizac et al. · Trials · 2020 · 15 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +12